when will tirzepatide go off patent FDA confirms shortage is still over, gives compounders a grace period Looming GLP-1 drug patent expirations

People coming from daily injectable medications (like certain insulin protocols or BPC-157) sometimes carry the daily injection habit into their tirzepatide protocol

It mimics the naturally occurring hormone glucagon-like peptide-1, which your gut releases after eating

Eligibility and prescriptions are based on provider evaluation

Injection instructions for GLP-1 medications in the abdomen: For abdominal injections of your GLP-1 medication, choose a spot in the soft, fatty tissue at least 2 inches from your navel

That is a 30-percentage-point reduction in insulin resistance prevalence

After branded Mounjaro went into shortage in the United States, compounding pharmacies began producing tirzepatide preparations in concentrations that often differ from the branded version